[18F]-flutemetamol amyloid imaging along the continuum from normal cognitive status to Alzheimer's disease dementia.
Not Applicable
Completed
- Conditions
- Alzheimer's disease, mild cognitive impairment (MCI), and cognitive intact healthy control (HC) subjects
- Registration Number
- JPRN-jRCT1091220124
- Lead Sponsor
- Shizuo Hatashita
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
AD, MCI and HC subjects undergo cognitive testing, [11C]-PIB PET and [18F]-flutemetamol PET. Informed consent is obtained.
Exclusion Criteria
Other degenerative disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method